Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jul 1, 2022 | Post-IPO Debt | $450M | 1 | Royalty Pharma | — | Detail |
Jul 21, 2021 | Post-IPO Equity | $316.25M | — | — | — | Detail |
Jul 16, 2020 | Post-IPO Equity | $201.30M | — | — | — | Detail |
Feb 20, 2014 | Post-IPO Equity | $37.40M | — | — | — | Detail |
Jun 19, 2012 | Post-IPO Equity | $42.50M | — | — | — | Detail |
Apr 19, 2011 | Post-IPO Equity | $20M | 1 | Deepfield | — | Detail |
Jan 18, 2006 | Post-IPO Equity | $33M | 2 | — | — | Detail |
Apr 29, 2004 | IPO | $89.70M | — | — | — | Detail |
Mar 31, 2003 | Series E | $40M | 1 | Vulcan | — | Detail |